AGP
CVS icon

Aspire Growth Partners’s CVS Health CVS Stock Holding History

Aspire Growth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Sell
4,667
-301
-6% -$23.2K 0.23% 87
2025
Q4 		$394K Buy
4,968
+43
+0.9% +$3.39K 0.27% 82
2025
Q3 		$371K Sell
4,925
-404
-8% -$27.7K 0.27% 82
2025
Q2 		$368K Sell
5,329
-358
-6% -$23.5K 0.3% 78
2025
Q1 		$380K Buy
5,687
+291
+5% +$17.4K 0.34% 71
2024
Q4 		$242K Buy
+5,396
New +$303K 0.24% 87

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aspire Growth Partners's CVS Position: Q1 2026 in Review

Aspire Growth Partners reduced its CVS Health (CVS) stake by 6.1% in Q1 2026, selling an estimated $23.2K and leaving 4,667 shares worth $335K. The position accounts for 0.23% of the portfolio, ranked #87.

Aspire Growth Partners first reported a position in CVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $394K in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Aspire Growth Partners held 4,667 shares of CVS Health worth $335K as of Q1 2026.
  • Aspire Growth Partners sold 301 CVS Health shares in Q1 2026, an estimated $23.2K.
  • CVS Health made up 0.23% of Aspire Growth Partners's portfolio in Q1 2026, its #87 holding.
  • Aspire Growth Partners first reported a position in CVS Health in Q4 2024 and has held it in 6 quarters since.
  • Aspire Growth Partners's CVS Health position peaked at $394K in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.